Abstract:Abstract Pediatric glioblastoma multiforme (pGBM) is a highly aggressive brain tumor with poor prognosis. Resistance to ionizing radiation, which is one of the major therapeutic regimes, is believed to play a critical role in tumor recurrence and ultimate treatment failure. However, little is known about the cellular and molecular mechanisms of radioresistance in pGBM, particularly the in vivo responses of tumor cells toward clinically relevant fractionated radiotherapy. To gain a better understanding of the radioresistance mechanisms, we administered fractionated radiation (2Gy per day × 5 times) to SCID mice bearing pre-established orthotopic xenograft tumors derived from two independent fresh patient tumors. Examination of the xenograft tumors immediately at the end of radiation treatment showed that the fractionated radiotherapy significantly increased the abundance of CD133+ tumor cells, and drove quiescent G0 phase cells (both CD133+ and CD133-) into G1 phase in both models. Immunohistochemical examination of key regulators of stem cell self-renewal revealed elevation of BMI-1 and SOX2 gene expression in vivo in the xenograft tumors. Additionally, we found that radiotherapy promoted mesenchymal transition, as the intensity and distribution of fibronectin, a mesenchymal marker, was remarkably enhanced. Further analysis of the recurrent xenograft tumors ∼ 5 weeks post-fractionated radiation showed that the increased CD133+ fraction, the elevated expressions of BMI-1 and SOX2 as well as fibronection were maintained. In conclusion, our data demonstrated, for the first time, that failure of radiotherapy is mediated by activated pathways related to self-renewal of cancer stem cells and mesenchymal transition. Since this study was conducted in vivo in clinically relevant animal models in a setting that is the closest to human brain tumors, our findings provided strong preclinical evidence to suggest that new stratigies are needed to inhibit these radiation triggered-pathways to improved therapeutic efficacy in pediatric GBM patient. Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 102nd Annual Meeting of the American Association for Cancer Research; 2011 Apr 2-6; Orlando, FL. Philadelphia (PA): AACR; Cancer Res 2011;71(8 Suppl):Abstract nr 570. doi:10.1158/1538-7445.AM2011-570

Downregulated CLIP3 induces radioresistance by enhancing stemness and glycolytic flux in glioblastoma

Protective properties of radio-chemoresistant glioblastoma stem cell clones are associated with metabolic adaptation to reduced glucose dependence

Upregulation of DNA Metabolism-Related Genes Contributes to Radioresistance of Glioblastoma.

Targeting Glioblastoma Stem Cells with 2-Deoxy-D-Glucose (2-DG) Potentiates Radiation-Induced Unfolded Protein Response (UPR)

Glut-3 Gene Knockdown as a Potential Strategy to Overcome Glioblastoma Radioresistance

STEM-20. RADIO-SENSITIZING GLIOBLASTOMA CANCER STEM CELLS BY INHIBITION OF FACT

Abstract 2872: GLUT3 promotes metabolic plasticity that drives radiation resistance in glioblastoma

Abstract 570: Radiation Resistance of Orthotopic Glioblastoma Xenografts is Mediated by Increasing CD133+ Cell Fraction, Mobilizing G0 Cells into G1 Phase, and Activating Self-Renewal and Mesenchymal Genes

Stem-16. Exploring The Role Of Hypoxia And Macrophages On Glioblastoma Quiescence And Stemness As Mediators Of Radioresistance

IMMU-19. TARGETING GLIOBLASTOMA IMMUNOSUPPRESSION AND TREATMENT RESISTANCE WITH IBRUTINIB IN COMBINATION WITH STEREOTACTIC RADIATION AND IMMUNE CHECKPOINT BLOCKADE

Combined EGFR and autophagy modulation impairs cell migration and enhances radiosensitivity in human glioblastoma cells

Downregulation of BMI1 Induces Glioma Stem Cells Sensitive to Radiation

Radioresistance of mesenchymal glioblastoma initiating cells correlates with patient outcome and is associated with activation of inflammatory program

STEM-43. GSK3β PROMOTES THE BMX-MEDIATED STAT3 ACTIVATION TO MAINTAIN GLIOBLASTOMA STEM CELLS

Smoothened Promotes Glioblastoma Radiation Resistance Via Activating USP3-Mediated Claspin Deubiquitination.

Simultaneous Modulation of Hypoxia And Metabolism in Glioblastoma for Enhanced Radio‐Immunotherapy

Reversing Epigenetic Gene Silencing to Overcome Immune Evasion in CNS Malignancies

Myeloid cells coordinately induce glioma cell-intrinsic and cell-extrinsic pathways for chemoresistance via GP130 signaling

CircFOXO3 upregulation mediates the radioresistance of glioblastoma by affecting cellular metabolome

DDDR-10. MYELOID CELLS COORDINATELY INDUCE GLIOMA CELL-INTRINSIC AND -EXTRINSIC PATHWAYS FOR CHEMORESISTANCE VIA GP130 SIGNALING

SPI1-mediated MIR222HG transcription promotes proneural-to-mesenchymal transition of glioma stem cells and immunosuppressive polarization of macrophages